Exchange: NYSE
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
The "insider return" statistic is based on the return generated (during the period shown) by a portfolio consisting of long positions in the stock corresponding to each purchase and short positions for each sale. The "insider grade" is calculated by testing the statistical significance of the timing of the insiders' trades; a grade of A means that if the same trades were made with random timing, there would be no more than a 5% chance of exceeding the insiders' return.
| Date | Insider | Relationship | Transaction Type | Number of Shares | Price | Market Value |
|---|---|---|---|---|---|---|
| 248 found. 1 through 20 displayed. 1 2 3 4 5 6 7 8 9 10 11 12 13 [Next] | ||||||
| 2/25/2013 | Kenneth C. Frazier | Chairman, President & Chief Executive Officer | A | 25,484 | 42.52 | $1,083,580 |
| 2/25/2013 | Peter S. Kim, PhD | Executive Vice President & President-MRL | A | 18,903 | 42.52 | $803,756 |
| 2/25/2013 | Willie A. Deese, MBA | Executive Vice President & President-MMD | A | 9,567 | 42.52 | $406,789 |
| 2/25/2013 | Peter N. Kellogg, MBA | Chief Financial Officer & Executive Vice President | A | 17,178 | 42.52 | $730,409 |
| 2/25/2013 | Bruce N. Kuhlik | EVP & General Counsel | A | 12,959 | 42.52 | $551,017 |
| 2/25/2013 | Adam H. Schechter | President-Global Human Health & EVP | A | 8,136 | 42.52 | $345,943 |
| 2/25/2013 | Mirian M. Graddick-Weir, PhD | Executive Vice President-Human Resources | A | 8,618 | 42.52 | $366,437 |
| 2/25/2013 | Clark Golestani | Chief Information Officer & EVP | A | 1,289 | 42.52 | $54,808 |
| 2/25/2013 | Michael Rosenblatt | Chief Medical Officer & EVP | A | 5,392 | 42.52 | $229,268 |
| 2/25/2013 | Adele D. Ambrose | Chief Communications Officer & Senior VP | A | 2,108 | 42.52 | $89,632 |
| 2/25/2013 | John Canan | Senior Vice President-Finance | A | 2,657 | 42.52 | $112,976 |
| 2/25/2013 | Bridgette P. Heller, MBA | Executive Vice President | A | 7,174 | 42.52 | $305,038 |
| 2/19/2013 | Adam H. Schechter | President-Global Human Health & EVP | F | 3,238 | 41.42 | $134,118 |
| 2/19/2013 | Adam H. Schechter | President-Global Human Health & EVP | M | 10,670 | 0.00 | $0 |
| 2/19/2013 | Michael Rosenblatt | Chief Medical Officer & EVP | F | 5,616 | 41.42 | $232,615 |
| 2/19/2013 | Michael Rosenblatt | Chief Medical Officer & EVP | M | 15,000 | 0.00 | $0 |
| 11/12/2012 | Bruce N. Kuhlik | EVP & General Counsel | S | 61,380 | 44.02 | $2,701,948 |
| 11/12/2012 | Bruce N. Kuhlik | EVP & General Counsel | M | 500 | 34.47 | $17,235 |
| 11/12/2012 | Bruce N. Kuhlik | EVP & General Counsel | M | 10,000 | 32.72 | $327,200 |
| 11/12/2012 | Bruce N. Kuhlik | EVP & General Counsel | M | 20,880 | 35.09 | $732,679 |
